8-K: Abacus Life Reports Strong First Quarter 2024 Revenue Growth, Despite Net Loss

Abacus Life's first quarter 2024 revenue more than doubled year-over-year, driven by growth in its direct-to-consumer division, though the company reported a net loss due to increased expenses.

Summary

• Abacus Life reported a significant increase in total revenue for the first quarter of 2024, reaching $21.5 million, more than double the $10.3 million reported in the same period last year.
• This revenue growth was primarily fueled by a 59% year-over-year increase in the direct-to-consumer division.
• Despite the revenue surge, the company experienced a GAAP net loss attributable to shareholders of $1.3 million, a downturn from the $8.1 million net income in the prior-year period.
• The net loss was mainly due to higher interest expenses, a $5.8 million non-cash expense related to employee stock compensation, and public company expenses.
• Adjusted net income for the quarter was $6.7 million, down from $7.6 million in the prior year.
• Adjusted EBITDA saw a 38.1% increase to $11.6 million, compared to $8.4 million in the prior year, though the adjusted EBITDA margin decreased to 53.9% from 81.4%.
• The company's annualized return on invested capital (ROIC) was 15%, and the annualized return on equity (ROE) was 16%.
• Abacus deployed $33.3 million in originations capital, a slight decrease from $34.4 million in the prior year, but policy originations grew by 6% to 119.
• The company repurchased 966,000 shares of its common stock at an average price of $11.41, totaling approximately $11 million, as part of its $15 million stock repurchase program.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While revenue growth is strong, the net loss and decreased profitability margins are concerning. The company is making strategic moves, but the financial results are not entirely positive.

Positives

• Abacus Life experienced significant revenue growth, more than doubling year-over-year to $21.5 million.
• The direct-to-consumer division showed strong growth, increasing by 59% year-over-year.
• Adjusted EBITDA increased by 38.1% to $11.6 million, indicating improved operational profitability.
• The company achieved a 15% annualized return on invested capital (ROIC) and a 16% annualized return on equity (ROE).
• Abacus successfully launched its technology subdivision, ABL Tech, and raised $25 million through senior notes.
• The company actively repurchased shares, demonstrating confidence in its value.

Negatives

• Abacus Life reported a GAAP net loss of $1.3 million, a significant decrease from the $8.1 million net income in the prior-year period.
• The net loss was primarily driven by higher interest expenses, a $5.8 million non-cash stock compensation expense, and public company expenses.
• Adjusted net income decreased to $6.7 million from $7.6 million in the prior year.
• The adjusted EBITDA margin decreased to 53.9% from 81.4% in the prior year, indicating a reduction in profitability relative to revenue.

Risks

• The company's loss reserves are based on estimates and may be inadequate to cover actual losses.
• There is a risk of failure to properly price insurance policies.
• The company's business is geographically concentrated, which could pose a risk.
• The industry is cyclical, which could impact performance.
• Regulation could have an impact on the business.
• Competition could negatively affect the company's business.
• The company relies on relationships with independent agencies, which could be a risk.
• There is a risk of failure to meet investment objectives.
• The company may be unable to raise capital on favorable terms or at all.
• Acts of terrorism could impact the business.
• There is a risk of control deficiencies.

Future Outlook

The company remains focused on delivering on its key strategic priorities by leveraging its technology and data advantages to further drive shareholder value. They also plan to continue to repurchase shares under the existing program.

Management Comments

• We are pleased with our continued momentum, delivering yet another strong quarterly performance due to our relentless execution, and further validating the resiliency and profitability of our business model, said Jay Jackson, Chief Executive Officer of Abacus.
• We remain focused and committed to delivering on our key strategic priorities by leveraging our considerable technology and data advantages to further drive shareholder value.

Industry Context

Abacus Life operates in the alternative asset management space, specifically focusing on life settlements. The company's growth in the direct-to-consumer division reflects a broader trend of increased consumer engagement in alternative investments. The launch of ABL Tech also indicates a move towards leveraging technology to enhance its offerings, which is a common theme in the financial services industry.

Comparison to Industry Standards

• While Abacus Life's revenue growth is impressive, the decrease in net income and adjusted EBITDA margin raises concerns when compared to industry peers.
• Companies like GWG Holdings (prior to its bankruptcy) and Life Partners Holdings (also facing challenges) have operated in the life settlement space, but direct comparisons are difficult due to varying business models and financial health.
• The 15% ROIC and 16% ROE are solid, but need to be compared against other alternative asset managers to determine if they are above or below average.
• The company's focus on technology through ABL Tech is a positive step, as many financial firms are investing heavily in technology to improve efficiency and customer experience.
• The repurchase of shares is a common practice among public companies, but the impact on shareholder value needs to be assessed over time.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the net loss and decreased profitability margins, despite the strong revenue growth.
• Employees may be impacted by the company's performance and strategic changes.
• Customers may benefit from the company's growth and new technology offerings.
• Suppliers and creditors may be impacted by the company's financial performance.

Next Steps

• The company will hold a webcast and conference call to discuss the results.
• Abacus will continue to execute its strategic priorities.
• The company will continue to repurchase shares under the existing program.

Key Dates

Keywords

life settlements, alternative asset management, longevity, actuarial technology, revenue growth, EBITDA, net loss, stock repurchase, financial results, senior notes